Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain

Overview of attention for article published in Frontiers in endocrinology, August 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter: 21 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 32 X posts from 21 X users, with an upper bound of 39,782 followers.

Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain https://t.co/ThegMAASbi #ScientiaVH

26 Sep 2023

Reply Repost Favourite

Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain https://t.co/8Df8506o02 #hvhebron #endo [Text complet] @FrontEndocrinol

22 Sep 2023

Reply Repost Favourite

Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain. [https://t.co/FWdIZKaOsI] @GVAlaRibera #DifundeCienciaHUR Dra. Fajardo

13 Sep 2023

Reply Repost Favourite

RT @NeuroendocrinoS: Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in 🇪🇸 @cristinala…

10 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 28 additional X posts.